Abstract
Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have